---
title: "Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: Humanistic burden and health-related quality of life"
description: "Formulary evidence on Adrabetadex (Lembaz, VTS-270) in Infantile-onset Niemann-Pick disease type C: Humanistic burden and health-related quality of life. Topics: Effects on wellbeing and quality of life in the 2025 guideline; Survey and interviews of caregivers and adult patients in the United States and United Kingdom; Patient HRQOL domains affected, from the caregiver perspective; Caregiver HRQOL; 3 further topics. 7 evidence topics quoted from 5 sources."
canonical: "https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/product-information-and-disease-description/humanistic-burden-and-health-related-quality-of-life"
published: "2026-11-19T12:08:36-05:00"
modified: "2026-11-19T12:08:36-05:00"
---

# Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: Humanistic burden and health-related quality of life

<a id="heading-2.2.1.8.1"></a>

## 2.2.1.8.1 Humanistic Burden and Health-related Quality of Life

<a id="topic-2.2.1.8.1-1"></a>

### Effects on wellbeing and quality of life in the 2025 guideline

> “As a progressive disease, these challenges translate to worse clinical outcomes, adverse effects on individuals' overall wellbeing and quality of life (QoL), and reduced life expectancy”

Source: [Hiwot et al. (2026)](https://pmc.ncbi.nlm.nih.gov/articles/PMC13110917/)

<a id="topic-2.2.1.8.1-2"></a>

### Survey and interviews of caregivers and adult patients in the United States and United Kingdom

> “A survey of caregivers for patients with NPC and adult patients with NPC (n = 49; patient age: 13 months–65 years) assessed NPC severity, importance of NPC symptoms, and how symptoms impacted patients’ and caregivers’ activities of daily living (ADLs) and health-related QOL (HRQOL).”
> “A total of 49 surveys were completed across two countries: 37 in the US and 12 in the United Kingdom (UK).”
> “Findings indicated that the most important manifestations of NPC were ambulation, swallowing, speech, fine motor skills, and cognition, which were those that had the most significant impact on ADLs and HRQOL.”
> “ADLs and HRQOL were impaired in the majority of patients as well as their caregivers.”
> “The findings were independent of current age, age of onset of symptoms, and level of NPC disease-related disability; however, the impact increased at higher levels of disease disability.”

Source: [Mengel et al. (2021b)](https://pmc.ncbi.nlm.nih.gov/articles/PMC8611877/)

<a id="topic-2.2.1.8.1-3"></a>

### Patient HRQOL domains affected, from the caregiver perspective

> “NPC and the impact it has upon ADLs also has a further effect upon patients’ HRQOL in a number of ways, with considerable impact on all major domains of HRQOL: emotional (n = 26; 92.9%), physical (n = 24; 85.7%), psychological (n = 10; 35.7%), and social (n = 22; 78.6%).”
> “Participants reported feelings of social isolation, loss of enjoyment in activities (patients), and feelings of sadness or worry (caregivers).”

Source: [Mengel et al. (2021b)](https://pmc.ncbi.nlm.nih.gov/articles/PMC8611877/)

<a id="topic-2.2.1.8.1-4"></a>

### Caregiver HRQOL

> “The impact of NPC on caregivers’ HRQOL was reported by many participants (n = 15; 53.6%) as summarized in Table 7, which also presents example quotes to illustrate the impact.”
> “Emotional impacts were those most commonly reported by caregivers, who discussed feelings of sadness, worry, anxiety, or distress about the impacts NPC was having on the patient, and reported feeling they were always on alert, being concerned about the patient suffering an injury, illness, or deteriorating due to their NPC.”

Source: [Mengel et al. (2021b)](https://pmc.ncbi.nlm.nih.gov/articles/PMC8611877/)

<a id="topic-2.2.1.8.1-5"></a>

### Focus groups with 19 patients and caregivers

> “To further grasp patient and caregiver perceptions and experiences with NPC, we carried out focus group discussions with pediatric and adult individuals with NPC (N = 19), with partial or full representation of the patient by their caregiver.”
> “Focus group discussions revealed that neurological signs, including declining cognition, memory loss, and psychiatric symptoms, as well as increasingly impaired mobility and motor function, are among the most pressing past and current concerns for patients and caregivers.”
> “Moreover, several participants also expressed concern over a loss of independence, social exclusion, and uncertainty for what the future holds.”

Source: [Golden et al. (2023)](https://pmc.ncbi.nlm.nih.gov/articles/PMC10200045/)

<a id="topic-2.2.1.8.1-6"></a>

### Disease-specific proxy-rated quality-of-life scales for children and adults

> “No scales currently exist to measure the impact of medication, physical therapy or clinical trials.”
> “NPC quality-of-life questionnaires for children (NPCQLQ-C) and adults (NPCQLQ-A) proxy prototype scales were produced and completed by 23 parents/carers of children (child age mean = 8.61 years) and 20 parents/carers of adults (adult age = 33.4 years).”
> “Reliability analysis resulted in a 15-item NPCQLQ-C and a 30-item NPCQLQ-A, which showed excellent internal consistency, Cronbach’s α = 0.925 and 0.947, respectively.”

Source: [Aston et al. (2019)](https://pmc.ncbi.nlm.nih.gov/articles/PMC6803578/)

<a id="topic-2.2.1.8.1-7"></a>

### Generic HRQOL instrument scores in eight Dutch adults

> “Eight patients with genetically confirmed NP-C were recruited from two Dutch University Medical Centers.”
> “All patients scored significantly lower on physical domains of HRQoL.”
> “The health related quality of life in our cohort, measured with the RAND-36, was on several domains significantly lowered compared to the general population”
> “Especially the general health perception was scored remarkably low, 35.0 on a scale of 0–100.”

Source: [Koens et al. (2016)](https://pmc.ncbi.nlm.nih.gov/articles/PMC5007743/)

## Related pages
- [Adrabetadex (Lembaz): Infantile-onset Niemann-Pick disease type C](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c.md)
- [Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: Terms and abbreviations](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/terms-and-abbreviations) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/terms-and-abbreviations.md)
- [Adrabetadex (Lembaz): Infantile-onset Niemann-Pick disease type C](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/executive-summary) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/executive-summary.md)
- [Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: Product information and disease description](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/product-information-and-disease-description) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/product-information-and-disease-description.md)
- [Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: Clinical evidence](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/clinical-evidence) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/clinical-evidence.md)
- [Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: Economic information and modeling report](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/economics) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/economics.md)
- [Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: References](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/references) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/references.md)
